miRNA-130a Targets ATG2B and DICER1 to Inhibit Autophagy and Trigger Killing of Chronic Lymphocytic Leukemia Cells

Toxicity and relapses from the immunochemotherapy used to treat chronic lymphocytic leukemia (CLL) prompt continued interest in gentle but effective targeted treatment options for the mainly elderly population suffering from this disease. Here, we report the definition of critical CLL cell survival...

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 72; no. 7; pp. 1763 - 1772
Main Authors Kovaleva, Valentina, Mora, Rodrigo, Park, Yoon Jung, Plass, Christoph, Chiramel, Abhilash I., Bartenschlager, Ralf, Döhner, Hartmut, Stilgenbauer, Stephan, Pscherer, Armin, Lichter, Peter, Seiffert, Martina
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Association for Cancer Research 01.04.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Toxicity and relapses from the immunochemotherapy used to treat chronic lymphocytic leukemia (CLL) prompt continued interest in gentle but effective targeted treatment options for the mainly elderly population suffering from this disease. Here, we report the definition of critical CLL cell survival pathways that can be targeted by ectopic reexpression of the miRNA genes miR-130a and miR-143 which are widely downregulated in CLL. Notably, miR-130a inhibited autophagy by reducing autophagosome formation, an effect mediated by downregulation of the genes ATG2B and DICER1, the latter of which is a major component of the miRNA silencing machinery. In support of the concept of a fundamental connection between miRNA disregulation and altered autophagic flux in this cancer, we showed that RNA interference–mediated knockdown of DICER1 expression was sufficient to reduce autophagy in primary or established cultures of CLL cells. Together, our findings show that miR-130a modulates cell survival programs by regulating autophagic flux, and they define roles for miR-130a and Dicer1 in a regulatory feedback loop that mediates CLL cell survival. Cancer Res; 72(7); 1763–72. ©2012 AACR.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0008-5472
1538-7445
1538-7445
DOI:10.1158/0008-5472.CAN-11-3671